177 related articles for article (PubMed ID: 31879189)
21. Increased sensitivity to light-induced damage in a mouse model of autosomal dominant retinal disease.
White DA; Fritz JJ; Hauswirth WW; Kaushal S; Lewin AS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):1942-51. PubMed ID: 17460245
[TBL] [Abstract][Full Text] [Related]
22. Functional rescue of P23H rhodopsin photoreceptors by gene delivery.
Gorbatyuk MS; Gorbatyuk OS; LaVail MM; Lin JH; Hauswirth WW; Lewin AS
Adv Exp Med Biol; 2012; 723():191-7. PubMed ID: 22183333
[TBL] [Abstract][Full Text] [Related]
23. CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa.
Wu WH; Tsai YT; Huang IW; Cheng CH; Hsu CW; Cui X; Ryu J; Quinn PMJ; Caruso SM; Lin CS; Tsang SH
Mol Ther; 2022 Apr; 30(4):1407-1420. PubMed ID: 35150888
[TBL] [Abstract][Full Text] [Related]
24. In Vivo CRISPR/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in a Mouse Model of X-Linked Retinitis Pigmentosa.
Hu S; Du J; Chen N; Jia R; Zhang J; Liu X; Yang L
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):31. PubMed ID: 32330228
[TBL] [Abstract][Full Text] [Related]
25. Repair of Retinal Degeneration following Ex Vivo Minicircle DNA Gene Therapy and Transplantation of Corrected Photoreceptor Progenitors.
Barnea-Cramer AO; Singh M; Fischer D; De Silva S; McClements ME; Barnard AR; MacLaren RE
Mol Ther; 2020 Mar; 28(3):830-844. PubMed ID: 32027843
[TBL] [Abstract][Full Text] [Related]
26. Endoplasmic reticulum stress in vertebrate mutant rhodopsin models of retinal degeneration.
Kroeger H; LaVail MM; Lin JH
Adv Exp Med Biol; 2014; 801():585-92. PubMed ID: 24664747
[TBL] [Abstract][Full Text] [Related]
27. Limited ATF4 Expression in Degenerating Retinas with Ongoing ER Stress Promotes Photoreceptor Survival in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa.
Bhootada Y; Kotla P; Zolotukhin S; Gorbatyuk O; Bebok Z; Athar M; Gorbatyuk M
PLoS One; 2016; 11(5):e0154779. PubMed ID: 27144303
[TBL] [Abstract][Full Text] [Related]
28. Silencing gene therapy for mutant membrane, secretory, and lipid proteins in retinitis pigmentosa (RP).
Shinohara T; Mulhern ML; Madson CJ
Med Hypotheses; 2008; 70(2):378-80. PubMed ID: 17590524
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy in animal models of autosomal dominant retinitis pigmentosa.
Rossmiller B; Mao H; Lewin AS
Mol Vis; 2012; 18():2479-96. PubMed ID: 23077406
[TBL] [Abstract][Full Text] [Related]
30. In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa.
Cideciyan AV; Jacobson SG; Aleman TS; Gu D; Pearce-Kelling SE; Sumaroka A; Acland GM; Aguirre GD
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5233-8. PubMed ID: 15784735
[TBL] [Abstract][Full Text] [Related]
31. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa.
Portera-Cailliau C; Sung CH; Nathans J; Adler R
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):974-8. PubMed ID: 8302876
[TBL] [Abstract][Full Text] [Related]
32. Retinal histopathology of an autopsy eye with advanced retinitis pigmentosa in a family with rhodopsin Glu181Lys.
To K; Adamian M; Dryja TP; Berson EL
Am J Ophthalmol; 2000 Dec; 130(6):790-2. PubMed ID: 11124299
[TBL] [Abstract][Full Text] [Related]
33. Looking into eyes: rhodopsin pathologies in Drosophila.
Griciuc A; Aron L; Ueffing M
Adv Exp Med Biol; 2012; 723():415-23. PubMed ID: 22183360
[No Abstract] [Full Text] [Related]
34. Clinically Relevant Outcome Measures for the I307N Rhodopsin Mouse: A Model of Inducible Autosomal Dominant Retinitis Pigmentosa.
Massengill MT; Young B; Patel D; Jafri F; Sabogal E; Ash N; Li H; Ildefonso CJ; Lewin AS
Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5417-5430. PubMed ID: 30452595
[TBL] [Abstract][Full Text] [Related]
35. Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78.
Gorbatyuk MS; Knox T; LaVail MM; Gorbatyuk OS; Noorwez SM; Hauswirth WW; Lin JH; Muzyczka N; Lewin AS
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5961-6. PubMed ID: 20231467
[TBL] [Abstract][Full Text] [Related]
36. Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.
Orlans HO; McClements ME; Barnard AR; Martinez-Fernandez de la Camara C; MacLaren RE
Nat Commun; 2021 Aug; 12(1):4934. PubMed ID: 34400638
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effect of Bcl-2 and BAG-1 on the prevention of photoreceptor cell death.
Eversole-Cire P; Concepcion FA; Simon MI; Takayama S; Reed JC; Chen J
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1953-61. PubMed ID: 10845622
[TBL] [Abstract][Full Text] [Related]
38. Gene-based therapies for dominantly inherited retinopathies.
Farrar GJ; Millington-Ward S; Chadderton N; Humphries P; Kenna PF
Gene Ther; 2012 Feb; 19(2):137-44. PubMed ID: 22089493
[TBL] [Abstract][Full Text] [Related]
39. AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse.
Liang FQ; Dejneka NS; Cohen DR; Krasnoperova NV; Lem J; Maguire AM; Dudus L; Fisher KJ; Bennett J
Mol Ther; 2001 Feb; 3(2):241-8. PubMed ID: 11237681
[TBL] [Abstract][Full Text] [Related]
40. Histopathologic study of variation in severity of retinitis pigmentosa due to the dominant rhodopsin mutation Pro23His.
To K; Adamian M; Dryja TP; Berson EL
Am J Ophthalmol; 2002 Aug; 134(2):290-3. PubMed ID: 12140048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
